ClinicalTrials.govpublic full text
Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
liver transplantation, tacrolimus, treatment outcome, immunosuppression, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 859454
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.